Human Papillomavirus Vaccine Hesitancy and Barriers in Achieving 100% Vaccine Coverage: A Web-based Cross-sectional Study

人乳头瘤病毒疫苗犹豫及实现100%疫苗覆盖率的障碍:一项基于网络的横断面研究

阅读:1

Abstract

INTRODUCTION: The human papillomavirus (HPV) vaccine is one of the most effective primary measures to prevent HPV-related infections and deadly cancers. Despite the availability of the HPV vaccine in the market for almost 17 years, it still remains underutilized. This study is planned with the objective to find out the reasons for vaccine hesitancy (VH) among the Indian population. MATERIALS AND METHODS: Web-based cross-sectional study done using a snowball sampling method. A prevalidated questionnaire containing 15 items was circulated through social media, and responses were evaluated for causes of VH. RESULTS: Out of 1018 study participants, the majority were between 15 and 20 years (64.1%) of age. Most participants were females (60.5% vs. 39.5%). Out of all, 37.8% were sexually active. Most (99%) of the study participants did not have any children. The majority were students (72.2%). Most (87%) had heard about HPV vaccination, and teachers (46.2%) were the most common source of their information. Only 15.4% of the participants were aware that the vaccine was for both boys and girls. Only 15.9% knew that HPV vaccination can protect from genital warts, oropharyngeal carcinoma, cervical cancer, anal cancer, and vulvar and vaginal cancers. The majority (80.9%) were unvaccinated, and unawareness about the vaccine was the most common reason (38.2%) for that. Among vaccinated, majority experienced no major side effects (90.2%). CONCLUSION: VH is one of the major barriers limiting 100% utilization of HPV vaccine across the country and needs to be addressed to combat the HPV virus-related disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。